TELA Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
TELA Bio, Inc. (TELA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 69.20% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-11
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-03-31 was 69.70%, a 4.65% decline year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-03-31 was 73.10%, a 0.27% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 72.90%, a 0.95% decline year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 73.60%, a 9.20% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 72.60%, a 0.82% decline from fiscal 2024.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 73.20%, a 1.48% decline from fiscal 2023.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 74.30%, a 6.75% increase from fiscal 2022.
- TELA Bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 69.60%, a 8.92% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 69.20% 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 69.70% 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 72.60% 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 72.60% 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 72.60% 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | 73.10% 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 73.20% 10-K · filed 2026-03-25 | |||
| 2024-09-30 | 73.20% 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | 73.20% 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | 72.90% 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | 74.30% 10-K · filed 2026-03-25 | |||
| 2023-09-30 | 74.30% 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 74.30% 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | 73.60% 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 69.60% 10-K · filed 2025-03-21 | |||
| 2022-09-30 | 68.90% 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 68.40% 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 67.40% 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | 63.90% 10-K · filed 2024-03-22 | |||
| 2021-09-30 | 63.80% 10-Q · filed 2021-11-12 | |||
| 2021-06-30 | 64.20% 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 64.30% 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | 59.10% 10-K · filed 2023-03-23 | |||
| 2020-09-30 | 58.60% 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | 58.30% 10-Q · filed 2020-08-13 | |||
| 2020-03-31 | 55.50% 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | 55.90% 10-K · filed 2022-03-23 | |||
| 2019-09-30 | 55.95% 10-Q · filed 2019-12-18 | |||
| 2018-12-31 | 56.50% 10-K · filed 2021-03-25 | |||
| 2017-12-31 | 50.00% 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |